Johnson & Johnson is being forced into a shareholder vote today, Thursday,
April 28, at its 2022 Annual Shareholder meeting to end all sales of its
talc-based baby powder globally. The company ceased sales of the product
in the US and Canada in 2020 due to public pressure and dropping sales
after the public learned asbestos had been found in the talc-based baby
product, but Johnson & Johnson has continued to sell its infamous
baby powder worldwide.
There have been over 34,000 lawsuits alleging that asbestos contaminated
Johnson & Johnson Baby Powder causes ovarian cancer and mesothelioma,
and the company has spent billions in settlements and court costs, but
Johnson & Johnson refuses to acknowledge the talc-based product poses
any potential health risk. Lest we forget, a
2018 Reuter’s expose showed internal company documents which proved that Johnson & Johnson
was aware that their product had at times been contaminated with asbestos
and worked hard to keep that information from the public.
Johnson & Johnson sent a
letter to the US Securities and Exchange Committee (SEC) to try and block the
vote on the basis it would affect the thousands of pending lawsuits in
state and federal courts worldwide, but the SEC is allowing the vote to proceed.
The Guardian: Johnson & Johnson shareholders called on to end talc
baby powder sales